AWE Study

  • Research type

    Research Study

  • Full title

    Influence of Age, Weight and Ethnic background on blood pressure: AWE Study

  • IRAS ID

    143911

  • Contact name

    Carmel McEniery

  • Contact email

    cmm41@cam.ac.uk

  • Sponsor organisation

    Cambridge University Hospitals NHS Foundation Trust and University of Cambridge

  • Duration of Study in the UK

    5 years, 0 months, 0 days

  • Research summary

    Hypertension, also known as high blood pressure, is a chronic medical condition, in which the blood pressure in the arteries is elevated. This is a common condition, which can lead to severe complications such as cardiovascular disease, myocardial infarction, stroke and kidney disease, if not detected and treated early.

    Accumulating evidence suggests that the incidence of hypertension varies based on age, ethnicity and obesity. In order to obtain an in-depth knowledge of the pathophysiological mechanisms of this disease, we aim to investigate the haemodynamic and biochemical correlates of elevated blood pressure across the adult age-span, and determine the extent to which body size and ethnicity impact on these associations, and investigate the impact of hypertension on key organ systems (end-organ damage). Improving the understanding of the influences of age, weight and ethnicity in hypertensive patients will have a positive impact for the treatment of this disease. Herein, we provide a combined case-control and cross-sectional study describing the procedures and time commitment required to investigate our scientific aims.

    This is a single centre study that will be conducted in a secondary care environment. Both male and females aged 18 and over and that are able provide informed consent will be considered for this study. Potential participants who are pregnant, currently receiving dialysis, illness with a life expectancy <1 year, current active malignancy and cannot provide informed consent are ineligible for this study. The study will be open for five years and each patient will complete a maximum of four visits in a 12 month period. Participants will complete a variety of non-invasive physiological assessments of their cardiovascular system and lung function. There will be some minimally invasive procedures completed, including a blood test and assessment of small artery endothelial function which involves insertion of a small needle under local anaesthetic.

  • REC name

    West Midlands - Coventry & Warwickshire Research Ethics Committee

  • REC reference

    16/WM/0485

  • Date of REC Opinion

    4 Jan 2017

  • REC opinion

    Further Information Favourable Opinion